Ionis, Novartis' key experimental heart drug fails in late-stage trial

Ionis Pharmaceuticals and partner Novartis' experimental drug to lower ​high levels of a cholesterol-carrying particle ‌in heart patients failed in a late-stage trial, the companies said on Friday.

本文内容来自外部来源，点击「继续访问」将跳转到原始发布站点。